PMID: 6107589Nov 1, 1980Paper

Poisoning by Cortinarius speciosissimus

Lancet
A I ShortJ S Robson

Abstract

Severe renal failure caused by the mushroom Cortinarius speciosissimus was first recognised in 1972 and has been reported only from Scandinavia. In the summer of 1979 and following the consumption of the wild mushroom in Scotland, three previously healthy young adults developed the recognised features of cortinarius poisoning-namely, gastrointestinal upset after 36-38h, followed by nausea, anorexia, headache, rigors, severe burning thirst, muscle aching, and oliguria. One patient had a diuresis after 8 days and recovered completely. The two other patients did not present to hospital until 10 days after ingestion and severe renal failure had already developed. Both had a severe interstitial nephritis and neither recovered renal function. They were maintained on intermittent haemodialysis until they received renal transplants 9 months later. This form of mushroom poisoning has not so far been reported in the British Isles. With the increasing popularity of wild-mushroom eating, posters and publications on wild edible foods should contain warnings about the toxic nature of species of the genus Cortinarius.

References

Sep 1, 1975·Zeitschrift Für Naturforschung. Section C: Biosciences·M MöttönenH Heikkilä

❮ Previous
Next ❯

Citations

Jan 1, 1990·Intensive Care Medicine·J BougetR Thomas
May 15, 1984·Experientia·I R Tebbett, B Caddy
Dec 15, 1982·Experientia·B CaddyR Watling
Dec 1, 1993·Toxicon : Official Journal of the International Society on Toxinology·C Köppel
Feb 15, 2005·The Journal of Emergency Medicine·Kyan J Berger, David A Guss
Feb 27, 2001·Toxicon : Official Journal of the International Society on Toxinology·V C DanelD Garon
Sep 25, 2003·Toxicon : Official Journal of the International Society on Toxinology·Christine Karlson-Stiber, Hans Persson
Jan 28, 1989·Lancet·C AndaryG Huchard
Aug 26, 1998·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·C R Warden, D R Benjamin
Jul 3, 2002·Drugs·Lars E Schmidt, Kim Dalhoff
Nov 13, 2001·American Journal of Clinical Dermatology·A L Kuijpers, P C van de Kerkhof
Jan 1, 1997·Journal of Toxicology. Clinical Toxicology·A M LeathemP D Kroeger
Aug 1, 1984·Human Toxicology·J HolmdahlJ Ahlmén
Nov 11, 2015·Human & Experimental Toxicology·Ricardo Jorge Dinis-OliveiraFélix Carvalho
Jun 19, 1998·American Journal of Medical Genetics·D M St ClairG A Machin
Oct 27, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R G KilnerJ B Eastwood
Oct 26, 2012·QJM : Monthly Journal of the Association of Physicians·P NagarajaM Kumwenda
Feb 5, 2015·Hemodialysis International·Pasquale EspositoAntonio Dal Canton
Jan 20, 2005·The Journal of Emergency Medicine·Kyan J Berger, David A Guss
Oct 11, 2012·Journal of Natural Products·Anders HerrmannKarl-Erik Hellenäs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.